TN 30 (10-23)
108.00 Skin Disorders (Effective Date
10/06/23)
A. Which
skin disorders do we evaluate under these listings? We use these listings to evaluate skin disorders that result from hereditary, congenital,
or acquired pathological processes. We evaluate genetic photosensitivity disorders
(108.07), burns (108.08), and chronic conditions of the skin or mucous membranes such
as ichthyosis, bullous disease, dermatitis, psoriasis, and hidradenitis suppurativa
(108.09) under these listings.
B. What
are our definitions for the following terms used in this body
system?
1. Assistive device(s): An assistive device, for the purposes of these listings, is any device used to improve
stability, dexterity, or mobility. An assistive device can be hand-held, such as a
cane(s), a crutch(es), or a walker; used in a seated position, such as a wheelchair,
rollator, or power operated vehicle; or worn, such as a prosthesis or an orthosis.
2. Chronic skin lesions: Chronic skin lesions can have recurrent exacerbations (see 108.00B7). They can occur
despite prescribed medical treatment. These chronic skin lesions can develop on any
part of your body, including upper extremities, lower extremities, palms of your hands,
soles of your feet, the perineum, inguinal (groin) region, and axillae (underarms).
Chronic skin lesions may result in functional limitations as described in 108.00D2.
3. Contractures: Contractures are permanent fibrous scar tissue resulting in tightening and thickening
of skin that prevents normal movement of the damaged area. They can develop on any
part of your musculoskeletal system, including upper extremities, lower extremities,
palms of your hands, soles of your feet, the perineum, inguinal (groin) region, and
axillae (underarms). Contractures may result in functional limitations as described
in 108.00D2.
4. Documented medical need: When we use the term “documented medical need,” we mean that there is evidence (see
§ 416.913 of this chapter) from your medical source(s) in the medical record that supports
your need for an assistive device (see 108.00B1) for a continuous period of at least
12 months. The evidence must include documentation from your medical source(s) describing
any limitation(s) in your upper or lower extremity functioning that supports your
need for the assistive device and describing the circumstances for which you need
it. The evidence does not have to include a specific prescription for the device.
5. Fine and gross movements: Fine movements, for the purposes of these listings, involve use of your wrists, hands,
and fingers; such movements include picking, pinching, manipulating, and fingering.
Gross movements involve use of your shoulders, upper arms, forearms, and hands; such
movements include handling, gripping, grasping, holding, turning, and reaching. Gross
movements also include exertional activities such as lifting, carrying, pushing, and
pulling. Evaluation of fine and gross movements is dependent on your age.
6. Surgical management: For the purposes of these listings, surgical management includes the surgery(ies)
itself, as well as various post-surgical procedures, surgical complications, infections
or other medical complications, related illnesses, or related treatments that delay
a person's attainment of maximum benefit from surgery.
7. Exacerbation: For the purposes of these listings, exacerbation means an increase in the signs or
symptoms of the skin disorder. Exacerbation may also be referred to as flare, flare-up,
or worsening of the skin disorder.
C. What
evidence do we need to evaluate your skin disorder?
1. To establish the presence of a skin disorder as a medically determinable impairment,
we need objective medical evidence from an acceptable medical source (AMS) who has
examined you for the disorder.
2. We will make every reasonable effort to obtain your medical history, treatment
records, and relevant laboratory findings, but we will not purchase genetic testing.
3. When we evaluate the presence and severity of your skin disorder(s), we generally
need information regarding:
a. The onset, duration, and frequency of exacerbations (see 108.00B7);
b. The prognosis of your skin disorder;
c. The location, size, and appearance of lesions and contractures;
d. Any available history of familial incidence;
e. Your exposure to toxins, allergens or irritants; seasonal variations; and stress
factors;
f. Your ability to function outside of a highly protective environment (see 108.00E4);
g. Laboratory findings (for example, a biopsy obtained independently of Social Security
disability evaluation or results of blood tests);
h. Evidence from other medically acceptable methods consistent with the prevailing
state of medical knowledge and clinical practice; and
i. Statements you or others make about your disorder(s), your restrictions, and your
daily activities.
D. How
do we evaluate the severity of skin disorders?
1. General. We evaluate the severity of skin disorders based on the site(s) of your chronic skin
lesions (see 108.00B2) or contractures (see 108.00B3), functional limitations caused
by your signs and symptoms (including pain) (see 108.00D2), and how your prescribed
treatment affects you. We consider the frequency and severity of your exacerbations
(see 108.00B7), how quickly they resolve, and how you function between exacerbations
(see 108.00B7), to determine whether your skin disorder meets or medically equals
a listing (see 108.00D3). If there is no record of ongoing medical treatment for your
disorder, we will follow the guidelines in 108.00D6. We will determine the extent
and kinds of evidence we need from medical and non-medical sources based on the individual
facts about your disorder. For our basic rules on evidence, see §§ 416.912, 416.913, and 416.920b of this chapter. For our rules on evaluating your symptoms, see § 416.929 of this chapter.
2. Limitation(s) of physical functioning due to skin
disorders.
a. Skin disorders may be due to chronic skin lesions (see 108.00B2) or contractures
(see 108.00B3), and may cause pain or restrict movement, which can limit your ability
to initiate, sustain, and complete age-appropriate activities. For example, skin lesions
in the axilla may limit your ability to raise or reach with the affected arm, or lesions
in the inguinal region may limit your ability to ambulate, sit, or lift and carry.
To evaluate your skin disorder(s) under 108.07B, 108.08, and 108.09, we require medically
documented evidence of physical limitation(s) of functioning related to your disorder.
The decrease in physical function must have lasted, or can be expected to last, for
a continuous period of at least 12 months (see § 416.909 of this chapter). Xeroderma pigmentosum is the only skin disorder that does not include
functional criteria because the characteristics and severity of the disorder itself
are sufficient to meet the criteria in 108.07A.
b. The functional criteria require impairment-related physical limitations in using
upper or lower extremities that have lasted, or can be expected to last, for a continuous
period of at least 12 months, medically documented by one of the following:
(i) Inability to use both upper extremities to the extent that neither can be used
to independently initiate, sustain, and complete age-appropriate activities involving
fine and gross movements (see 108.00B5) due to chronic skin lesions (see 108.00B2)
or contractures (see 108.00B3); or
(ii) Inability to use one upper extremity to independently initiate, sustain, and
complete age-appropriate activities involving fine and gross movements (see 108.00B5)
due to chronic skin lesions (see 108.00B2) or contractures (see 108.00B3), and a documented
medical need (see 108.00B4) for an assistive device (see 108.00B1) that requires the
use of the other upper extremity; or
(iii) Inability to stand up from a seated position and maintain an upright position
to the extent needed to independently initiate, sustain, and complete age-appropriate
activities due to chronic skin lesions (see 108.00B2) or contractures (see 108.00B3)
affecting at least two extremities (including when the limitations are due to involvement
of the perineum or the inguinal region); or
(iv) Inability to maintain an upright position while standing or walking to the extent
needed to independently initiate, sustain, and complete age-appropriate activities
due to chronic skin lesions (see 108.00B2) or contractures (see 108.00B3) affecting
both lower extremities (including when the limitations are due to involvement of the
perineum or the inguinal region).
3. Frequency of exacerbations due to chronic skin lesions. A skin disorder resulting in chronic skin lesions (see 108.00B2) may have frequent
exacerbations (see 108.00B7) severe enough to meet a listing even if each individual
skin lesion exacerbation (see 108.00B7) did not last for an extended amount of time.
We will consider the frequency, severity, and duration of skin lesion exacerbations
(see 108.00B7), how quickly they resolve, and how you function in the time between
skin lesion exacerbations (see 108.00B7), to determine whether your skin disorder
meets or medically equals a listing.
4. Symptoms (including pain). Your symptoms may be an important factor in our determination of whether your skin
disorder(s) meets or medically equals a listing. We consider your symptoms only when
you have a medically determinable impairment(s) that could reasonably be expected
to produce the symptoms. See § 416.929 of this chapter.
5. Treatment.
a. General. Treatments for skin disorders may have beneficial or adverse effects, and responses
to treatment vary from person to person. Your skin disorder's response to treatment
may vary due to treatment resistance or side effects that can result in functional
limitations. We will evaluate all of the effects of treatment (including surgical
treatment, medications, and therapy) on the symptoms, signs, and laboratory findings
of your skin disorder, and on your ability to function.
b. Despite adherence to prescribed medical treatment for 3
months. Under 108.09, we require that your symptoms persist “despite adherence to prescribed
medical treatment for 3 months.” This requirement means that you must have taken prescribed
medication(s) or followed other medical treatment prescribed by a medical source for
3 consecutive months. Treatment or effects of treatment may be temporary. In most
cases, sufficient time must elapse to allow us to evaluate your response to treatment,
including any side effects. For our purposes, “sufficient time” means a period of
at least 3 months. If your treatment has not lasted for at least 3 months, we will
follow the rules in 108.00D6a. The 3 months adherence to prescribed medical treatment
must be within the period of at least 12 months that we use to evaluate severity.
c. Treatment with PUVA (psoralen and ultraviolet A (UVA) light) or
biologics. If you receive additional treatment with PUVA or biologics to treat your skin disorder(s),
we will defer adjudication of your claim for 6 months from the start of treatment
with PUVA or biologics to evaluate the effectiveness of these treatments unless we
can make a fully favorable determination or decision on another basis.
6. No record of ongoing treatment.
a. Despite having a skin disorder, you may not have received ongoing treatment, may
have just begun treatment, may not have access to prescribed medical treatment, or
may not have an ongoing relationship with the medical community. In any of these situations,
you will not have a longitudinal medical record for us to review when we evaluate
your disorder. In some instances, we may be able to assess the severity and duration
of your skin disorder based on your medical record and current evidence alone. We
may ask you to attend a consultative examination to determine the severity and potential
duration of your skin disorder (see § 416.919a of this chapter).
b. If, for any reason, you have not received treatment, your skin disorder cannot
meet the criteria for 108.09. If the information in your case record is not sufficient
to show that you have a skin disorder that meets the criteria of one of the skin disorders
listings, we will follow the rules in 108.00I.
E. How do we evaluate genetic photosensitivity
disorders under 108.07?
Genetic photosensitivity disorders are disorders of the skin caused by an increase
in the sensitivity of the skin to sources of ultraviolet light, including sunlight.
1. Xeroderma pigmentosum
(XP)
(108.07A). XP is a genetic photosensitivity disorder with lifelong hypersensitivity to all forms
of ultraviolet light. Laboratory testing confirms the diagnosis by documenting abnormalities
in the body's ability to repair DNA (deoxyribonucleic acid) mutations after ultraviolet
light exposure. Your skin disorder meets the requirements of 108.07A if you have clinical
and laboratory findings supporting a diagnosis of XP (see 108.00E3).
2. Other genetic photosensitivity disorders
(108.07B).
The effects of other genetic photosensitivity disorders may vary and may not persist
over time. To meet the requirements of 108.07B, a genetic photosensitivity disorder
other than XP must be established by clinical and laboratory findings (see 108.00C)
and must result either in chronic skin lesions (see 108.00B2) or contractures (see
108.00B3) that result in functional limitations (108.00D2), or must result in the
inability to function outside of a highly protective environment (see 108.00E4). Some
genetic photosensitivity disorders can have very serious effects on other body systems,
especially special senses and speech, neurological, mental, and cancer. We will evaluate
your disorder(s) under the listings in 102.00, 111.00, 112.00, or 113.00, as appropriate.
3. What evidence do we need to document that you have XP or another genetic
photosensitivity disorder? We will make a reasonable effort to obtain evidence of your disorder(s), but we will
not purchase genetic testing. When the results of genetic tests are part of the existing
evidence in your case record, we will evaluate the test results with all other relevant
evidence. We need the following clinical and laboratory findings to document that
you have XP or another genetic photosensitivity disorder:
a. A laboratory report of a definitive genetic test documenting appropriate chromosomal
changes, including abnormal DNA repair or another DNA abnormality specific to your
type of photosensitivity disorder, signed by an AMS; or
b. A laboratory report of a definitive test that is not signed by an AMS, and a report
from an AMS stating that you have undergone definitive genetic laboratory studies
documenting appropriate chromosomal changes, including abnormal DNA repair or another
DNA abnormality specific to your type of photosensitivity disorder; or
c. If we do not have a laboratory report of a definitive test, we need documentation
from an AMS that an appropriate laboratory analysis or other diagnostic method(s)
confirms a positive diagnosis of your skin disorder. This documentation must state
that you had the appropriate definitive laboratory test(s) for diagnosing your disorder
and provide the results, or explain how another diagnostic method(s), consistent with
the prevailing state of medical knowledge and clinical practice, established your
diagnosis.
4. Inability to function outside of a highly protective environment means that you must avoid exposure to ultraviolet light (including sunlight passing
through windows and light from similar unshielded light sources), wear protective
clothing and eyeglasses, and use opaque broad-spectrum sunscreens in order to avoid
skin cancer or other serious effects.
F. How do we evaluate
burns under
108.08?
1. Electrical, chemical, or thermal burns frequently affect other body systems; for
example, musculoskeletal, special senses and speech, respiratory, cardiovascular,
genitourinary, neurological, or mental. We evaluate burns in the same way we evaluate
other disorders that can affect the skin and other body systems, using the listing
for the predominant feature of your disorder. For example, if your soft tissue injuries
resulting from burns are under surgical management (as defined in 108.00B6), we will
evaluate your disorder under the listings in 101.00.
2. We evaluate burns resulting in chronic skin lesions (see 108.00B2) or contractures
(see 108.00B3) that have been documented by an AMS to have reached maximum therapeutic
benefit and therefore are no longer receiving surgical management, under 108.08. To
be disabling, these burns must result in functional limitation(s) (see 108.00D2) that
has lasted or can be expected to last for a continuous period of at least 12 months.
G. How
do we evaluate chronic conditions of the skin or mucous membranes under 108.09? We evaluate skin disorders that result in chronic skin lesions (see 108.00B2) or
contractures (see 108.00B3) under 108.09. These disorders must result in chronic skin
lesions (see 108.00B2) or contractures (see 108.00B3) that continue to persist despite
adherence to prescribed medical treatment for 3 months (see 108.00D5b) and cause functional
limitations (see 108.00D2). Examples of skin disorders evaluated under this listing
are ichthyosis, bullous diseases (such as pemphigus, epidermolysis bullosa, and dermatitis
herpetiformis), chronic skin infections, dermatitis, psoriasis, and hidradenitis suppurativa.
H. How
do we evaluate disorders in other body systems that affect the skin? When your disorder(s) in another body system affects your skin, we first evaluate
the predominant feature of your disorder(s) under the appropriate body system. Examples
of disorders in other body systems that affect the skin include the following:
1. Tuberous sclerosis. The predominant functionally limiting features of tuberous sclerosis are seizures
and intellectual disorder or other mental disorders. We evaluate these features under
the listings in 111.00 or 112.00, as appropriate.
2. Malignant tumors of the skin. Malignant tumors of the skin (for example, malignant melanomas) are cancers, or malignant
neoplastic diseases, that we evaluate under the listings in 113.00.
3. Immune system disorders. We evaluate skin manifestations of immune system disorders such as systemic lupus
erythematosus, scleroderma, psoriasis, and human immunodeficiency virus (HIV) infection
under the listings in 114.00.
4. Head or facial disfigurement or deformity, and other physical
deformities caused by skin disorders. A head or facial disfigurement or deformity may result in loss of your sight, hearing,
speech, or ability to chew. In addition to head and facial disfigurement and deformity,
other physical deformities may result in associated psychological problems (for example,
depression). We evaluate the effects of head or facial disfigurement or deformity,
or other physical deformities caused by skin disorders under the listings in 101.00, 102.00, 105.00, or 112.00, as appropriate.
5. Porphyria. We evaluate erythropoietic protoporphyria under the listings in 107.00.
6. Hemangiomas. We evaluate hemangiomas associated with thrombocytopenia and hemorrhage (for example,
Kasabach-Merritt syndrome) involving coagulation defects under the listings in 107.00. When hemangiomas impinge on vital structures or interfere with functioning, we evaluate
their primary effects under the listings in the appropriate body system.
I. How do we evaluate skin disorders that do not meet one of these
listings?
1. These listings are only examples of common skin disorders that we consider severe
enough to result in marked and severe limitations. If your impairment(s) does not
meet the criteria of any of these listings, we must also consider whether you have
an impairment(s) that satisfies the criteria of a listing in another body system.
2. If you have a severe medically determinable impairment(s) that does not meet a
listing, we will determine whether your impairment(s) medically equals a listing.
See § 416.926 of this chapter. If your impairment(s) does not meet or medically equal a listing,
we will also consider whether your impairment(s) functionally equals the listings.
See § 416.926a of this chapter. We use the rules in § 416.994a of this chapter when we decide whether you continue to be disabled.
108.01 Category of Impairments, Skin Disorders
108.02-108.06 [Reserved]
108.07 Genetic photosensitivity disorders, established as described in 108.00E. The requirements of this listing are met if
either paragraph A or paragraph B is satisfied.
A. Xeroderma pigmentosum (see 108.00E1).
OR
B. Other genetic photosensitivity disorders (see 108.00E2) with either 1 or 2:
1. Chronic skin lesions (see 108.00B2) or contractures (see 108.00B3) that cause an
inability to function outside of a highly protective environment (see 108.00E4); or
2. Chronic skin lesions (see 108.00B2) or contractures (see 108.00B3) causing chronic
pain or other physical limitation(s) that result in impairment-related functional
limitations (see 108.00D2), as evidenced by:
a. Inability to use both upper extremities to the extent that neither can be used
to independently initiate, sustain, and complete age-appropriate activities involving
fine and gross movements (see 108.00B5) due to chronic skin lesions (see 108.00B2)
or contractures (see 108.00B3); or
b. Inability to use one upper extremity to independently initiate, sustain, and complete
age-appropriate activities involving fine and gross movements (see 108.00B5) due to
chronic skin lesions (see 108.00B2) or contractures (see 108.00B3), and a documented
medical need (see 108.00B4) for an assistive device (see 108.00B1) that requires the
use of the other upper extremity; or
c. Inability to stand up from a seated position and maintain an upright position to
the extent needed to independently initiate, sustain, and complete age-appropriate
activities due to chronic skin lesions (see 108.00B2) or contractures (see 108.00B3)
affecting at least two extremities (including when the limitations are due to involvement
of the perineum or the inguinal region); or
d. Inability to maintain an upright position while standing or walking to the extent
needed to independently initiate, sustain, and complete age-appropriate activities
due to chronic skin lesions (see 108.00B2) or contractures (see 108.00B3) affecting
both lower extremities (including when the limitations are due to involvement of the
perineum or the inguinal region).
108.08 Burns (see 108.00F). Burns that do not require continuing surgical management (see 108.00B6),
or that have been documented by an acceptable medical source to have reached maximum
therapeutic benefit and are no longer receiving surgical management, resulting in
chronic skin lesions (see 108.00B2) or contractures (see 108.00B3) causing chronic
pain or other physical limitation(s) that result in impairment-related functional
limitations (see 108.00D2), as evidenced by:
A. Inability to use both upper extremities to the extent that neither can be used to
independently initiate, sustain, and complete age-appropriate activities involving
fine and gross movements (see 108.00B5) due to chronic skin lesions (see 108.00B2)
or contractures (see 108.00B3).
OR
B. Inability to use one upper extremity to independently initiate, sustain, and complete
age-appropriate activities involving fine and gross movements (see 108.00B5) due to
chronic skin lesions (see 108.00B2) or contractures (see 108.00B3), and a documented
medical need (see 108.00B4) for an assistive device (see 108.00B1) that requires the
use of the other upper extremity.
OR
C. Inability to stand up from a seated position and maintain an upright position to
the extent needed to independently initiate, sustain, and complete age-appropriate
activities due to chronic skin lesions (see 108.00B2) or contractures (see 108.00B3)
affecting at least two extremities (including when the limitations are due to involvement
of the perineum or the inguinal region).
OR
D. Inability to maintain an upright position while standing or walking to the extent
needed to independently initiate, sustain, and complete age-appropriate activities
due to chronic skin lesions (see 108.00B2) or contractures (see 108.00B3) affecting
both lower extremities (including when the limitations are due to involvement of the
perineum or the inguinal region).
108.09 Chronic conditions of the skin or mucous
membranes (see 108.00G) resulting in:
A. Chronic skin lesions (see 108.00B2) or contractures (see 108.00B3) causing chronic
pain or other physical limitation(s) that persist despite adherence to prescribed
medical treatment for 3 months (see 108.00D5b).
AND
B. Impairment-related functional limitations (see 108.00D2) demonstrated by 1, 2, 3,
or 4:
1. Inability to use both upper extremities to the extent that neither can be used
to independently initiate, sustain, and complete age-appropriate activities involving
fine and gross movements (see 108.00B5) due to chronic skin lesions (see 108.00B2)
or contractures (see 108.00B3); or
2. Inability to use one upper extremity to independently initiate, sustain, and complete
age-appropriate activities involving fine and gross movements (see 108.00B5) due to
chronic skin lesions (see 108.00B2) or contractures (see 108.00B3), and a documented
medical need (see 108.00B4) for an assistive device (see 108.00B1) that requires the
use of the other upper extremity; or
3. Inability to stand up from a seated position and maintain an upright position to
the extent needed to independently initiate, sustain, and complete age-appropriate
activities due to chronic skin lesions (see 108.00B2) or contractures (see 108.00B3)
affecting at least two extremities (including when the limitations are due to involvement
of the perineum or the inguinal region); or
4. Inability to maintain an upright position while standing or walking to the extent
needed to independently initiate, sustain, and complete age-appropriate activities
due to chronic skin lesions (see 108.00B2) or contractures (see 108.00B3) affecting
both lower extremities (including when the limitations are due to involvement of the
perineum or the inguinal region).